Patent application number | Description | Published |
20080234383 | Novel Compounds, Isomer Thereof, or Pharmaceutically Acceptable Salts Thereof as Vanilloid Receptor Antagonist; and Pharmaceutical Compositions Containing the Same - This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receotor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease. | 09-25-2008 |
20080280976 | Composition Comprising the Alcohol Compound Isolated from the Extract of Cucurbitaceae Family Plant Having Anti-Adipogenic and Anti-Obesity Activity - The present invention is related to an alcohol compound isolated from the extract of Cucurbitaceae family plant having anti-adipogenic and anti-obesity activity, and a composition comprising the same. The compound showed potent reducing activity of body weight, decreasing effect on the blood triglyceride and cholesterol level, activating activity of PPAR α and preventing activity from the adipogenesis of precursor fat cells with no toxicity, therefore, those extract can be useful in treating or preventing obesity and adipogenesis-involved diseases as a medicine or health care food. | 11-13-2008 |
20080287440 | Novel Antifungal Triazole Derivatives - Disclosed herein are antifungal triazole derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same. The triazole derivatives of Chemical Formula 1 or pharmaceutically acceptable salts thereof according to the present invention have excellent inhibitory activity against a broad spectrum of fungi, in addition to being safe to the body, and thus are very useful in the treatment and prevention of fungal infection. | 11-20-2008 |
20080312234 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on. | 12-18-2008 |
20090036501 | 2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha - 2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-α or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-α or PDE4. | 02-05-2009 |
20090105258 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salt thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease. | 04-23-2009 |
20100048570 | THIAZOLIDINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF - The present invention relates to novel 2-carbonyl-3-acyl-1,3-thiazolidines having a β-amino group on the acyl chain, in free, prodrug form or pharmaceutically acceptable salt thereof, including their enantiomers, diastereomers and racemates, as efficient inhibitors against DPP-IV. The invention further relates to the pharmaceutical compositions comprising the disclosed compounds. The present invention also relates to methods for preparing the disclosed compounds and for treating DPP-IV-mediated diseases. | 02-25-2010 |
20100162316 | DISPLAY APPARATUS AND CONTROL METHOD THEREOF - The present invention relates to a display apparatus and a control method thereof. The display apparatus according to the present invention includes a display unit; a contents processing unit that processes contents; a user input unit that inputs control signals to retrieve the contents; a control unit that, if the control signals are continuously input, controls the contents processing unit to display minimum contents data on the display unit, retrieves contents corresponding to the control signals continuously input upon completion of inputting the control signals, and controls the contents processing unit to display the retrieved contents on the display unit. With this configuration, a display apparatus and a control method thereof, being capable of promptly reacting with a user's input and displaying contents, are provided. | 06-24-2010 |
20100185988 | Apparatus and method for providing graphic user interface - An apparatus and method for providing a graphic user interface which is used in a display device operated by a remote controller are provided. A graphic user interface screen includes a main information display area for displaying main information in the form in which a plurality of main elements are recursively disposed and a sub-information display area for displaying sub-information including supplementary information according to information provided on the main information display area. At least one sub-element included in a main element is operated by a direction selection signal which indicates a direction perpendicular to a disposition direction of the main elements. | 07-22-2010 |
20100291243 | EXTRACTOR HAVING POTTERY WITH A DARK BROWN GLAZE AND THE METHOD FOR EXTRACTING USING THEREOF - Disclosed are an extractor having a “pottery with dark brown glaze” called “Onggi” in Korean, and a method of extracting using the same. The extractor includes a body, a body cover, a heating part, a pottery and a gas valve. The pottery is located within the body. The extractor extracts by injecting nitrogen gas, etc. into the body through a gas valve, thereby rendering the inside of the body to be high pressure state during extraction. Thus, the inside of the body is maintained under high pressure during extraction. Accordingly, an extract is located only within the pottery, and thus changes that can be caused while an extract contacts with the body can be prevented. | 11-18-2010 |
20110015230 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - This present disclosure relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. | 01-20-2011 |
20110152318 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, heart disease and so on. | 06-23-2011 |
20110268706 | PREPARATION METHOD OF POROUS HYALURONIC ACID SPONGE FOR CELL DELIVERY SYSTEM - Provided is a preparation method of a porous hyaluronic acid sponge comprising the steps of: dissolving hyaluronic acid in an aqueous sodium hydroxide solution; adding an epoxy-based crosslinking agent to the resultant aqueous sodium hydroxide solution in which hyaluronic acid is dissolved and homogenizing the hyaluronic acid solution; hydrogelating the homogenized hyaluronic acid solution; washing the hydrogelated hyaluronic acid hydrogel with ultrapure water; swelling the washed hyaluronic acid hydrogel to attain porosity; and freeze-drying the hyaluronic acid hydrogel to obtain a porous hyaluronic acid sponge. | 11-03-2011 |
20130206977 | METHOD FOR CRYSTALLIZING LOW MASS IONS FOR DIAGNOSING COLORECTAL CANCER AND METHOD FOR DIAGNOSING COLORECTAL CANCER USING SAME - The present invention provides a method for crystallizing low mass ions for diagnosing colorectal cancer by using a MALDI-TOF mass spectrometer to biostatistically analyze low mass ions, which are extracted from a biological sample, and a method for providing information for diagnosing colorectal cancer using same. The present inventions can provide a diagnostic method, which requires low cost and a short time for analysis, can analyze large areas, and which can provide superior and credible discriminations. | 08-15-2013 |
20140011881 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - This present disclosure relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. | 01-09-2014 |
20140160165 | AUGMENTED REALITY SYSTEM USING MOVING CEILING TRANSPARENT DISPLAY FOR SHIP AND METHOD FOR ENABLING SAME - In an augmented reality system using a moving ceiling transparent display for a ship, according to the present invention, the moving ceiling transparent display is movably installed on the ceiling of a steering house of the ship, and the system comprises: a recognition portion for recognizing the location of the ship and the direction of the head and the pupils of a sailor; a reception portion for receiving external image data from an external landscape database with respect to an external landscape, in accordance with the location of the ship and the direction of the head and the pupils of the sailor; a matching portion for adjusting a match between the external image data, which is received by the receiving portion, and an actual external image through the window; and an output portion for outputting through the transparent display information on the external image data, which is adjusted through the matching portion, on the location of the actual external image. | 06-12-2014 |
20150019874 | APPARATUS AND METHOD FOR GENERATING ELECTRONIC BOOK, AND APPARATUS AND METHOD FOR VERIFYING INTEGRITY OF ELECTRONIC BOOK - Disclosed are an apparatus and method for generating an electronic book (e-book) and an apparatus and method for verifying integrity of an e-book. An e-book including information for verifying the integrity of the e-book is generated, and the integrity of an e-book is verified from information included in the e-book to determine whether or not the e-book has been falsified. Accordingly, an e-book is generated to conform to the electronic publication (EPUB) standard and to include information for protecting the copyright of the e-book, so that the e-book market can be activated. | 01-15-2015 |
20150026456 | APPARATUS AND METHOD FOR MANAGING DIGITAL COPYRIGHT ON EPUB-BASED CONTENT, AND APPARATUS AND METHOD FOR PROVIDING EPUB-BASED CONTENT ACCORDING TO USER'S RIGHT - Disclosed are an apparatus and method for managing a digital copyright on electronic publication (EPUB)-based content and an apparatus and method for providing EPUB-based content according to a user's right. An encryption unit of the apparatus for managing digital copyright generates encrypted unit files by encrypting a plurality of unit files included in content in the form of a compressed archive including the plurality of unit files with different encryption keys, stores the encrypted unit files in a content database, generates mapping data by mapping the encryption keys to pieces of identification information of the encrypted unit files, and stores the mapping data in an encryption key database. A rights management unit transmits an encryption key selected from among the plurality of encryption keys to a content provision apparatus, which decrypts the encrypted unit files and provides the unit files to a user, based on at least one of identification information of the user and identification information of the content included in an encryption key provision request message received from the content provision apparatus. | 01-22-2015 |
20150062048 | ELECTRONIC APPARATUS AND METHOD FOR OUTPUTTING CONTENT - An electronic apparatus and a method of outputting content of the electronic apparatus outputs a synchronized content to a display apparatus and a projection-type display apparatus and a method of outputting a content of the electronic apparatus. The electronic apparatus includes an input/output unit connected with a display apparatus and a projection-type display apparatus, and a control unit configured to control the input/output unit, wherein the control unit outputs a synchronized content to the display apparatus and the projection-type display apparatus through the input/output unit. | 03-05-2015 |